The Importance of LDL-C Lowering with Evolocumab in Recent ACS
[Speaker] Jung-Won Suh/Seoul National Univ.,Korea
PCSK9 Inhibition: Beyond LDL-C Lowering Effect in ACS Patients
[Speaker] Young-Hoon Jeong/Gyeongsang National Univ.,Korea
Discussion